Michal Kriegelstein

Michal Kriegelstein

Auto-generated profile, based on publicly available information

Michal Kriegelstein

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czechia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

3 September 2020 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
MKMichal Kriegelstein
Michal Kriegelstein
DPDavid Profous
David Profous
APAdam Přibylka
Adam Přibylka
PCPetr Cankař
Petr Cankař

9 July 2025 in The Journal of Organic Chemistry
Verified
Journal Article
Open access
DPDavid Profous
David Profous
MKMichal Kriegelstein
Michal Kriegelstein
PJPetr Jurecka
Petr Jurecka
PCPetr Cankař
Petr Cankař
Axially chiral 2-(2-(trifluoromethyl)-1H-benzo[d]imidazol-1-yl)benzoic acid (TBBA) was employed as a chiral derivatizing agent for determining the absolute α-configuration of primary amines and secondary alcohols via 19F NMR spectroscopy. The method utilizes the trifluoromethyl group as a sensor, detecting the shielding effects induced by individual alcohol or amine substituents. This approach was tested on 46 alcohols and amines, demonstrating greater efficiency compared to the standard MTPA method.

1 November 2021 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Closed access
PDF file
MKMichal Kriegelstein
Michal Kriegelstein
MHMiloš Hroch
Miloš Hroch
AMAleš Marek
Aleš Marek

18 January 2025 in Journal of Pharmaceutical Analysis
Verified
Journal Article
Open access
AMAleš Marek
Aleš Marek
BBBřetislav Brož
Břetislav Brož
MKMichal Kriegelstein
Michal Kriegelstein
GNGabriela Nováková
Gabriela Nováková
JHJana Hojcsková
Jana Hojcsková
LMLenka Maletínská
Lenka Maletínská
The preparation of specifically iodine-125 (125I)-labeled peptides of high purity and specific activity represents a key tool for the detailed characterization of their binding properties in interaction with their binding partners. Early synthetic methods for the incorporation of iodine faced challenges such as harsh reaction conditions, the use of strong oxidants and low reproducibility. Herein, we review well-established radiolabeling strategies available to incorporate radionuclide into a protein of interest, and our long-term experience with a mild, simple and generally applicable technique of 125I late-stage-labeling of biomolecules using the Pierce iodination reagent for the direct solid-phase oxidation of radioactive iodide. General recommendations, tips, and details of optimized chromatographic conditions to isolate pure, specifically 125I-mono-labeled biomolecules are illustrated on a diverse series of (poly)peptides, ranging up to 7.6 kDa and 67 amino acids (aa). These series include peptides that contain at least one tyrosine or histidine residue, along with those featuring disulfide crosslinking or lipophilic derivatization. This mild and straightforward late-stage-labeling technique is easily applicable to longer and more sensitive proteins, as demonstrated in the cases of the insulin-like growth factor binding protein-3 (IGF-BP-3) (29 kDa and 264 aa) and the acid-labile subunit (ALS) (93 kDa and 578 aa).

1 November 2021 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MMMartin Mžik
Martin Mžik
NVNela Váňová
Nela Váňová
MKMichal Kriegelstein
Michal Kriegelstein
MHMiloš Hroch
Miloš Hroch